Justin Ferdinandus

Koeln, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

BrECADD in three days: Implementation of a condensed intensive first-line regimen in Hodgkin lymphoma.

BrECADD in three days: Implementation of a condensed intensive first-line regimen in Hodgkin lymphoma.

Journal: British journal of haematology

Published: June 23, 2026

Comparing a treatment combination that includes brentuximab vedotin with standard of care chemotherapy for treating advanced Hodgkin lymphoma: a plain language summary of the HD21 clinical study intended for patients and carers.

Comparing a treatment combination that includes brentuximab vedotin with standard of care chemotherapy for treating advanced Hodgkin lymphoma: a plain language summary of the HD21 clinical study intended for patients and carers.

Journal: Future oncology (London, England)

Published: May 13, 2026

Prognostic impact of presentation phenotypes in early-stage favorable Hodgkin lymphoma.

Prognostic impact of presentation phenotypes in early-stage favorable Hodgkin lymphoma.

Journal: Cancer

Published: March 21, 2026

BrECADD vs BEACOPP and Health-Related Quality of Life in Advanced-Stage Hodgkin Lymphoma.

BrECADD vs BEACOPP and Health-Related Quality of Life in Advanced-Stage Hodgkin Lymphoma.

Journal: JAMA oncology

Published: February 05, 2026

Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma.

Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma.

Journal: Blood advances

Published: January 13, 2026

Contrast-enhanced CT for attenuation correction in ultra-high sensitivity long-axial field-of-view lymphoma PET: amplified quantification problems?

Contrast-enhanced CT for attenuation correction in ultra-high sensitivity long-axial field-of-view lymphoma PET: amplified quantification problems?

Journal: EJNMMI physics

Published: December 25, 2025

Patient Perspective on Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Advanced-Stage Classic Hodgkin Lymphoma Treated With Multiagent Chemotherapy Regimens in the HD21 Trial.

Patient Perspective on Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Advanced-Stage Classic Hodgkin Lymphoma Treated With Multiagent Chemotherapy Regimens in the HD21 Trial.

Journal: Clinical lymphoma, myeloma & leukemia

Published: October 10, 2025

MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay.

MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay.

Journal: Blood

Published: September 15, 2025

MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay.

MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay.

Journal: Blood

Published: September 15, 2025

BrECADD and fertility: an ongoing concern - Authors' reply.

BrECADD and fertility: an ongoing concern - Authors' reply.

Journal: The Lancet. Oncology

Published: August 27, 2025

Anti-programmed cell death protein 1-based salvage therapy for relapsed/refractory Hodgkin lymphoma: a multicenter real-world analysis.

Anti-programmed cell death protein 1-based salvage therapy for relapsed/refractory Hodgkin lymphoma: a multicenter real-world analysis.

Journal: Haematologica

Published: August 18, 2025

Positron Emission Tomography-Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial.

Positron Emission Tomography-Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 17, 2025

Showing 1-12 of 61

Last Updated: 09/26/2026